Abivax (ABVX) Cash from Operations (2024 - 2025)
Abivax's (ABVX) quarterly Cash from Operations came in at 27004645.5 in Q4 2025, up 24.66% year-on-year from 21662958.62 in Q4 2024, and up 67.59% quarter-over-quarter from 83333754.08 in Q3 2025.
Abivax (ABVX) Cash from Operations (2024 - 2025) Analysis & Trends
Abivax's Cash from Operations history runs 2 years deep, the most recent figure standing at 27004645.5 for Q4 2025.
- On a quarterly basis, Cash from Operations rose 24.66% year-over-year to 27004645.5 in Q4 2025; TTM through Dec 2025 was 183082545.95, a 9.79% decrease from a year earlier, with the FY2025 full-year figure at 187527410.22, down 12.43% from the prior year.
- Cash from Operations advanced to 27004645.5 in Q4 2025 per ABVX's latest filing, from 83333754.08 in the prior quarter.
- Across five years, Cash from Operations topped out at 27004645.5 in Q4 2025 and bottomed at 83333754.08 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 201.34 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -354.17 Mn |
| 10 | Abivax | 9.98 Bn | 9.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27.00 Mn |
| Dec 31, 2025 | -27.00 Mn |
| Sep 30, 2025 | -83.33 Mn |
| Sep 30, 2025 | -83.33 Mn |
| Jun 30, 2025 | -37.74 Mn |
| Jun 30, 2025 | -37.74 Mn |
| Mar 31, 2025 | -35.00 Mn |
| Mar 31, 2025 | -35.00 Mn |
| Dec 31, 2024 | -35.84 Mn |
| Dec 31, 2024 | -35.84 Mn |
| Sep 30, 2024 | -38.86 Mn |
| Sep 30, 2024 | -38.86 Mn |
| Jun 30, 2024 | -54.30 Mn |
| Jun 30, 2024 | -54.30 Mn |
| Mar 31, 2024 | -37.76 Mn |
| Mar 31, 2024 | -37.76 Mn |